A Second Dose of a Measles-Mumps-Rubella Vaccine Administered to Healthy Four-To-Six-Year-Old Children: A Phase III, Observer-Blind, Randomized, Safety and Immunogenicity Study Comparing GSK MMR and MMR II With and Without DTaP-IPV and Varicella Vaccines Co-Administration
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1554971
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2019
Authors
Unknown
Publisher
Informa UK Limited
